Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Victoza in type 2 diabetes mellitus using insulin
NCT01628445Phase 3Terminated
- Sponsor
- University of Manitoba
- Start
- Aug 2012
- Primary completion
- Nov 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of liraglutide in type 2 diabetes mellitus (T2DM), sponsored by University of Manitoba. Started Aug 2012; status: terminated.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01628445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01628445.